PMID- 34850268 OWN - NLM STAT- MEDLINE DCOM- 20211224 LR - 20230517 IS - 1432-1963 (Electronic) IS - 0172-8113 (Print) IS - 0172-8113 (Linking) VI - 42 IP - Suppl 2 DP - 2021 Dec TI - [Clinical, radiological, and histopathological features of pulmonary post-COVID syndrome : A form of autoimmune-mediated interstitial lung disease?]. PG - 160-164 LID - 10.1007/s00292-021-01024-6 [doi] AB - BACKGROUND: About 10% of patients develop persistent symptoms after mild/moderate COVID-19. We have previously reported detection of antinuclear autoantibodies/extractable nuclear antigens (ANA/ENA) in patients with severe COVID-19. OBJECTIVES: The aim of this small pilot study was to characterize long-/post-COVID and to evaluate possible similarities between lung involvement in long-/post-COVID and connective tissue disease (CTD). METHODS: We prospectively enrolled 33 previously healthy patients with persistent pulmonal symptoms after mild/moderate COVID-19 without hospitalization (median age, 39 years). We performed clinical evaluation including pulmonary function tests, computed tomography (CT), and serology for ANA/ENA. In 29 of 33 patients, transbronchial biopsies (TBBs) were taken for histopathological assessment. RESULTS: Most patients presented with disturbed oxygen pulse in spiroergometry and slight lymphocytosis in bronchoalveolar lavage (BAL) fluid. The CT pattern showed bronchial wall thickening and increased low-attenuation volume. Autoantibodies were detected in 13 of 33 patients (39.4%). Histopathological assessment showed interstitial lymphocytosis with alveolar fibrin and organizing pneumonia. Ultrastructural analyses revealed interstitial collagen deposition. CONCLUSION: While histopathology of pulmonary long-/post-COVID alone is unspecific, the combination with clinical and radiological features together with detection of autoantibodies would allow for a diagnosis of interstitial pneumonia with autoimmune features (IPAF). Since we observe interstitial collagen deposition and since IPAF/CTD-ILD might progress to fibrosis, the persistence of autoantibodies and possible fibrotic change should be closely monitored in autoantibody-positive long-/post-COVID patients. CI - (c) 2021. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature. FAU - Steinestel, K AU - Steinestel K AD - Abt. XIII, Institut fur Pathologie und Molekularpathologie, Bundeswehrkrankenhaus Ulm, Oberer Eselsberg 40, 89081, Ulm, Deutschland. konradsteinestel@bundeswehr.org. FAU - Czech, A AU - Czech A AD - Abt. XIII, Institut fur Pathologie und Molekularpathologie, Bundeswehrkrankenhaus Ulm, Oberer Eselsberg 40, 89081, Ulm, Deutschland. FAU - Hackenbroch, C AU - Hackenbroch C AD - Abteilung Radiologie, Bundeswehrkrankenhaus Ulm, Ulm, Deutschland. FAU - Bloch, W AU - Bloch W AD - Molekulare und zellulare Sportmedizin, Deutsche Sporthochschule Koln, Koln, Deutschland. FAU - Gagiannis, D AU - Gagiannis D AD - Klinik fur Innere Medizin - Pneumologie, Bundeswehrkrankenhaus Ulm, Ulm, Deutschland. LA - ger PT - Journal Article PT - Review TT - Klinische, radiologische und histopathologische Merkmale des pulmonalen Post-COVID-Syndroms : Eine Form der autoimmunvermittelten interstitiellen Lungenerkrankung? DEP - 20211130 PL - Germany TA - Pathologe JT - Der Pathologe JID - 8006541 SB - IM MH - Adult MH - *COVID-19 MH - Humans MH - Lung/diagnostic imaging MH - *Lung Diseases, Interstitial MH - Pilot Projects MH - SARS-CoV-2 PMC - PMC8631553 OTO - NOTNLM OT - COVID-19 OT - Fibrosis OT - ILD OT - Long-COVID OT - SARS-CoV‑2 EDAT- 2021/12/02 06:00 MHDA- 2021/12/25 06:00 PMCR- 2021/11/30 CRDT- 2021/12/01 07:31 PHST- 2021/10/29 00:00 [accepted] PHST- 2021/12/02 06:00 [pubmed] PHST- 2021/12/25 06:00 [medline] PHST- 2021/12/01 07:31 [entrez] PHST- 2021/11/30 00:00 [pmc-release] AID - 10.1007/s00292-021-01024-6 [pii] AID - 1024 [pii] AID - 10.1007/s00292-021-01024-6 [doi] PST - ppublish SO - Pathologe. 2021 Dec;42(Suppl 2):160-164. doi: 10.1007/s00292-021-01024-6. Epub 2021 Nov 30.